PUT - SPRINTER OPEN END - SANOFI Share Price

Certificat

DE000VU5DL48

Delayed Deutsche Boerse AG 01:50:24 27/06/2024 pm IST
3.28 EUR +4.46% Intraday chart for PUT - SPRINTER OPEN END - SANOFI
Current month-4.56%
1 month-4.85%
Date Price Change
27/24/27 3.28 +4.46%
26/24/26 3.14 +2.61%
25/24/25 3.06 -4.38%
24/24/24 3.2 -7.25%
21/24/21 3.45 -0.86%

Delayed Quote Deutsche Boerse AG

Last update June 27, 2024 at 01:50 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying SANOFI
IssuerLogo Issuer Vontobel Vontobel
WKN VU5DL4
ISINDE000VU5DL48
Date issued 27/03/2023
Strike 122.8
Maturity Unlimited
Parity 10 : 1
Emission price 3.25
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.57
Lowest since issue 2.24
Spread 0.01
Spread %0.30%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
90.79 EUR
Average target price
108.2 EUR
Spread / Average Target
+19.17%
Consensus